Vestmark Advisory Solutions, Inc. Genmab A/S Transaction History

Vestmark Advisory Solutions, Inc.

$2.43 Billion
Q3 2024

A detailed history of Vestmark Advisory Solutions, Inc. transactions in Genmab A/S stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 27,979 shares of GMAB stock, worth $576,087. This represents 0.03% of its overall portfolio holdings.

Number of Shares

27,979

Previous 27,644 1.21%

Holding current value

$576,087

Previous $694,000 1.73%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.84 - $28.48 $7,986 - $9,540	335 Added 1.21%	27,979 $682,000
Q2 2024 Aug 12, 2024	SELL	$25.13 - $30.27 $11,710 - $14,105	-466 Reduced 1.66%	27,644 $694,000
Q1 2024 May 15, 2024	SELL	$26.43 - $32.77 $199,440 - $247,282	-7,546 Reduced 21.16%	28,110 $840,000
Q4 2023 Feb 06, 2024	BUY	$27.94 - $35.44 $220,865 - $280,153	7,905 Added 28.49%	35,656 $1.14 Million
Q3 2023 Nov 06, 2023	SELL	$35.27 - $42.24 $373,297 - $447,068	-10,584 Reduced 27.61%	27,751 $978,000
Q2 2023 Aug 07, 2023	BUY	$37.4 - $42.94 $14,997 - $17,218	401 Added 1.06%	38,335 $1.46 Million
Q1 2023 May 09, 2023	SELL	$34.88 - $43.22 $246,427 - $305,349	-7,065 Reduced 15.7%	37,934 $1.43 Million
Q4 2022 Jan 20, 2023	SELL	$33.8 - $47.06 $304,876 - $424,481	-9,020 Reduced 16.7%	44,999 $0
Q3 2022 Nov 03, 2022	BUY	$31.52 - $373.61 $468,954 - $5.56 Million	14,878 Added 38.01%	54,019 $1.74 Million
Q2 2022 Aug 04, 2022	BUY	$26.83 - $38.57 $466,681 - $670,886	17,394 Added 79.98%	39,141 $1.27 Million
Q1 2022 Apr 27, 2022	SELL	$30.95 - $39.68 $230,453 - $295,457	-7,446 Reduced 25.51%	21,747 $787,000
Q4 2021 Jan 31, 2022	SELL	$35.87 - $47.12 $56,818 - $74,638	-1,584 Reduced 5.15%	29,193 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $417,411 - $489,441	10,046 Added 48.46%	30,777 $1.35 Million
Q2 2021 Aug 09, 2021	BUY	$32.88 - $44.57 $211,122 - $286,183	6,421 Added 44.87%	20,731 $846,000
Q1 2021 May 10, 2021	SELL	$30.92 - $44.4 $144,241 - $207,126	-4,665 Reduced 24.58%	14,310 $470,000
Q4 2020 Feb 04, 2021	BUY	$33.66 - $40.76 $44,633 - $54,047	1,326 Added 7.51%	18,975 $772,000
Q3 2020 Oct 19, 2020	BUY	$33.07 - $38.68 $76,061 - $88,964	2,300 Added 14.98%	17,649 $646,000
Q2 2020 Aug 13, 2020	SELL	$20.05 - $33.89 $240 - $406	-12 Reduced 0.08%	15,349 $520,000
Q1 2020 May 06, 2020	BUY	$17.15 - $25.22 $24,215 - $35,610	1,412 Added 10.12%	15,361 $325,000
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $13,178 - $16,849	698 Added 5.27%	13,949 $311,000
Q3 2019 Nov 05, 2019	BUY	$18.0 - $21.38 $238,518 - $283,306	13,251 New	13,251 $268,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account

Vestmark Advisory Solutions, Inc. Genmab A/S Transaction History